IAM
BIIB icon

Impax Asset Management’s Biogen BIIB Stock Holding History

Impax Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$25.7M Buy
88,559
+18,000
+26% +$5.06M 1.52% 8
2018
Q1 		$19.3M Buy
70,559
+6,301
+10% +$1.96M 1.11% 28
2017
Q4 		$20.5M Sell
64,258
-22,988
-26% -$7.37M 1.18% 28
2017
Q3 		$27.3M Buy
87,246
+22,600
+35% +$6.69M 1.56% 11
2017
Q2 		$17.5M Buy
64,646
+12,100
+23% +$3.2M 0.99% 42
2017
Q1 		$14.4M Buy
52,546
+100
+0.2% +$28.3K 0.8% 54
2016
Q4 		$14.9M Buy
52,446
+25,518
+95% +$7.56M 0.85% 55
2016
Q3 		$8.43M Buy
26,928
+7,459
+38% +$2.21M 0.48% 89
2016
Q2 		$4.71M Buy
19,469
+12,150
+166% +$3.2M 0.27% 105
2016
Q1 		$1.91M Buy
7,319
+954
+15% +$252K 0.1% 149
2015
Q4 		$1.95M Buy
6,365
+556
+10% +$160K 0.11% 140
2015
Q3 		$1.7M Sell
5,809
-555
-9% -$183K 0.1% 141
2015
Q2 		$2.57M Buy
6,364
+188
+3% +$75.5K 0.14% 132
2015
Q1 		$2.61M Buy
6,176
+24
+0.4% +$9.46K 0.14% 136
2014
Q4 		$2.09M Buy
6,152
+217
+4% +$70.2K 0.12% 143
2014
Q3 		$1.96M Buy
5,935
+45
+0.8% +$14.8K 0.13% 132
2014
Q2 		$1.86M Buy
+5,890
New +$1.77M 0.12% 134

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Impax Asset Management's BIIB Position: Q2 2018 in Review

Impax Asset Management increased its Biogen (BIIB) stake by 26% in Q2 2018, buying an estimated $5.06M and bringing the position to 88,559 shares worth $25.7M. The position accounts for 1.52% of the portfolio, ranked #8.

Impax Asset Management first reported a position in BIIB in Q2 2014 and has held it in 17 quarters since. The position peaked at $27.3M in Q3 2017. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Impax Asset Management held 88,559 shares of Biogen worth $25.7M as of Q2 2018.
  • Impax Asset Management bought 18,000 Biogen shares in Q2 2018, an estimated $5.06M.
  • Biogen made up 1.52% of Impax Asset Management's portfolio in Q2 2018, its #8 holding.
  • Impax Asset Management first reported a position in Biogen in Q2 2014 and has held it in 17 quarters since.
  • Impax Asset Management's Biogen position peaked at $27.3M in Q3 2017.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.